Influenza Vaccination Coverage in Children: How Has COVID-19 Influenced It? A Review of Five Seasons (2018-2023) in Central Catalonia, Spain
- PMID: 39204048
- PMCID: PMC11358914
- DOI: 10.3390/vaccines12080925
Influenza Vaccination Coverage in Children: How Has COVID-19 Influenced It? A Review of Five Seasons (2018-2023) in Central Catalonia, Spain
Abstract
Influenza vaccination is the main method of preventing influenza. Vaccination is recommended for certain individuals with diseases that could cause complications in the case of flu infection. The objective of this retrospective observational study was to examine influenza vaccination coverage in patients with risk factors, to describe the characteristics of those vaccinated and to study the influence of COVID-19. The study population was children under 14 years old with risk factors between 2018/19 and 2022/23 in Central Catalonia, sourced through the electronic database of the Catalan Institute of Health. The association of influenza vaccination data with sociodemographic data and risk factors was performed by bivariate and multivariate analysis. A total of 13,137 children were studied. Of those, 4623 had received the influenza vaccine in at least one season. The average influenza vaccination rate was 28.8%. The statistically significant factors associated with vaccination were age and having certain risk factors: asthma, diabetes, haemoglobinopathies and clotting disorders. In all seasons, the immigrant population was vaccinated more than the native population p < 0.05, except for the COVID-19 season (2020/21), where no differences were observed. Of those vaccinated, 7.1% had been vaccinated for 5 consecutive years. Influenza vaccination coverage in the paediatric age group was low. Vaccination promotion measures must be implemented. COVID-19 meant an increase in vaccination of the native population to the same level as that of the immigrant population.
Keywords: COVID-19; children; influenza vaccine; vaccination coverage.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Acceptance or rejection of vaccination against influenza and SARS-CoV2 viruses among primary care professionals in Central Catalonia. A cross-sectional study.Vaccine X. 2023 Aug;14:100290. doi: 10.1016/j.jvacx.2023.100290. Epub 2023 Mar 26. Vaccine X. 2023. PMID: 37008959 Free PMC article.
-
Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.Health Technol Assess. 2020 Dec;24(67):1-66. doi: 10.3310/hta24670. Health Technol Assess. 2020. PMID: 33256892 Free PMC article.
-
Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.Infection. 2007 Oct;35(5):308-19. doi: 10.1007/s15010-007-6218-5. Epub 2007 Sep 20. Infection. 2007. PMID: 17885730
-
Influenza vaccine coverage among children under the age of 5 years in Poland during 2004-2008.Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):102-4. doi: 10.1186/2047-783x-15-s2-102. Eur J Med Res. 2010. PMID: 21147633 Free PMC article. Review.
-
Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.Vaccine. 2018 Jun 7;36(24):3434-3444. doi: 10.1016/j.vaccine.2018.04.049. Epub 2018 May 1. Vaccine. 2018. PMID: 29724509 Review.
References
-
- World Health Organization . Global Influenza Strategy 2019–2030. World Health Organization; Geneva, Switzerland: 2019. [(accessed on 15 May 2023)]. Available online: https://www.who.int/publications/i/item/9789241515320#:~:text=The%20Glob....
-
- World Health Organization Vaccines against influenza: WHO position paper-May 2022. Wkly. Epidemiol. Rec. 2022;19:185–208.
-
- Díaz-García R., Sánchez-Gómez A., Lópe-Zambrano M.A., Esteban-Vasallo M.D., Cañellas Llabrés S., Gutíerrrez Rodrígez M.A., Lasheras Carbajo M.D. Cobertura y adherencia a la vacunación frente a la gripe en menores de 15 años con condiciones de riesgo en la Comunidad de Madrid. An. Pediatr. 2023;98:3–11. doi: 10.1016/j.anpedi.2022.07.006. - DOI
-
- Instituto de Salud Carlos III Informe SiVIRA de Vigilancia de Gripe, COVID-19 y VRS. España, Temporada 2021–2022. Noviembre, 2022. [(accessed on 16 May 2023)]. Available online: https://cne.isciii.es/servicios/departamento-de-enfermedades-transmisibl....
Grants and funding
LinkOut - more resources
Full Text Sources